FLT1 and breast carcinoma: For example, HHEX inhibits cell proliferation through transcriptional repression of the VEGF signaling pathway components (VEGFA, VEGFR1, and VEGFR2) in leukemic K562 cells, breast cancer MCF7 cells, and HUVECs10,11,13.